
Our medical experts are ready to answer your questions and guide you through your treatment options.
Patients from Nigeria seeking embryo biopsy often face complex decisions regarding specialized fertility care. The concern for advanced genetic screening, coupled with ensuring safety and efficacy for a delicate procedure, leads many to explore options beyond their immediate borders. Understanding where to find reliable, high-quality treatment is a primary worry for families hoping to build their families.
Chennai has emerged as a preferred destination for international patients, including those from Nigeria, seeking advanced fertility treatments like embryo biopsy. The city's medical infrastructure is well-regarded, offering a focused care environment where fertility specialists and dedicated support teams work in close coordination. This makes the journey smoother for those traveling for such sensitive procedures.
Trust in Chennai's medical ecosystem for fertility care is built on its modern hospitals and experienced specialists. These facilities are equipped with state-of-the-art technology essential for precise procedures like embryo biopsy and subsequent genetic testing. Patients benefit from comprehensive care pathways, including easy access to follow-up consultations and coordinated support throughout their treatment cycle within the city.
Chennai offers a comprehensive and supportive environment for advanced fertility treatments.
Embryo biopsy is a micro-surgical procedure performed as part of an in vitro fertilization (IVF) cycle. It involves carefully removing a few cells from an early-stage embryo, typically at the blastocyst stage (Day 5 or 6 of development). These cells are then sent for genetic testing, such as Preimplantation Genetic Testing for Aneuploidy (PGT-A), Monogenic diseases (PGT-M), or Structural Rearrangements (PGT-SR). The primary purpose is to screen embryos for chromosomal abnormalities or specific genetic disorders before they are implanted into the uterus, aiming to improve IVF success rates and reduce the risk of passing on inherited conditions.
This is the most common and preferred method today. A small number of cells are taken from the trophectoderm, which is the outer layer of cells that will eventually form the placenta. This method is considered safer for the embryo's development and provides a larger sample for genetic analysis.
Historically, cells were sometimes removed from Day 3 embryos, which are typically 6-8 cell stage. This method is less common now due to concerns about potential embryo damage and the limited number of cells available for testing, which can sometimes lead to less conclusive results.
This involves removing polar bodies from the egg before fertilization or after fertilization but before the embryo develops. This method primarily screens for maternal genetic issues and does not assess paternal contributions or new mutations arising after fertilization.
Once the cells are biopsied, they undergo various tests: PGT-A screens for chromosomal abnormalities; PGT-M identifies specific single-gene disorders; and PGT-SR detects structural rearrangements in chromosomes.
The embryo biopsy procedure is an intricate part of an IVF cycle, beginning after egg retrieval and fertilization, culminating in genetic analysis.
The process starts with ovarian stimulation using fertility medications to produce multiple eggs. These eggs are then retrieved through a minor surgical procedure called transvaginal ovarian aspiration.
Retrieved eggs are fertilized with sperm in the laboratory (either through conventional IVF or ICSI). The resulting embryos are then cultured for five to six days until they reach the blastocyst stage.
Using a micro-manipulation system, a highly skilled embryologist creates a small opening in the outer shell of the blastocyst (zona pellucida) using a laser. A few cells from the trophectoderm are gently separated and removed. Care is taken to avoid disturbing the inner cell mass, which develops into the fetus.
The biopsied cells are then sent to a specialized genetics laboratory for analysis. The genetic report usually takes several days to a couple of weeks.
After biopsy, the embryos are typically cryopreserved (frozen) while awaiting the genetic test results. Only embryos identified as genetically normal are selected for transfer.
The direct recovery related to the embryo biopsy itself primarily concerns the viability of the biopsied embryos. Modern techniques ensure minimal impact on embryo development. For the patient, recovery after an embryo biopsy is largely tied to the egg retrieval procedure, which is generally swift, with most individuals resuming normal activities within a day or two. There are no specific recovery steps for the biopsy itself. Once genetic results are available, the focus shifts to preparing the uterus for a frozen embryo transfer, involving medication to optimize the uterine lining. Follow-up appointments will discuss the genetic report and plan the subsequent transfer.
Embryo biopsy coupled with PGT has a high success rate in accurately identifying genetic conditions, typically over 95%. While PGT does not guarantee a pregnancy, transferring genetically normal embryos significantly increases the chances of successful implantation and reduces the risk of miscarriage. Success rates for live birth after transferring a PGT-normal embryo can range from 50-70% per transfer, varying based on the patient's age and overall fertility factors.
The cost of embryo biopsy in Chennai is influenced by several factors, including the reputation and technology of the fertility clinic, the number of embryos being biopsied, and the extent of the genetic testing required (e.g., PGT-A, PGT-M). It is often part of a broader IVF package.
In Chennai, the cost for embryo biopsy, excluding the full IVF cycle, generally ranges from INR 35,000 to INR 65,000 per embryo, or a package for multiple embryos. This typically includes the biopsy procedure and the genetic testing.
Patients from around the world, including Nigeria, often find Chennai to be a cost-effective option for advanced fertility treatments like embryo biopsy, without compromising on quality or technology. Here’s a comparison:
| Location | Estimated Cost (USD) |
|---|---|
| Chennai, India | $500 - $900 per embryo (excluding IVF cycle) |
| United States | $1,500 - $2,500 per embryo |
| United Kingdom | $1,000 - $1,800 per embryo |
| Thailand | $800 - $1,500 per embryo |
| Singapore | $1,200 - $2,000 per embryo |
Choosing Chennai for embryo biopsy means opting for specialized care and advanced technology for your fertility journey.
India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.
Meet our team of highly qualified and experienced medical professionals dedicated to providing the best healthcare services.
Get Personalized Medical Treatment Options From India's Top Hospitals. Our Medical Experts Are Ready To Assist You Every Step Of The Way.